InsiderTrades.com logo
World's 2nd Richest Man Is About To Shock The World
From Legacy Research   |   Ad
Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry...
See what Elon is up to now.

OPK Insider Trading (OPKO Health)

Insider Ownership Percentage: 40.90%
Insider Buying (Last 12 Months): $11,732,999.13
Insider Selling (Last 12 Months): $0.00

OPKO Health Insider Trading History Chart

OPKO Health Share Price & Price History

$4.70
▲ +0.2 (4.44%)
As of 03/1/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
From Legacy Research   |   Ad
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click to see what happened

OPKO Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/19/2021Phillip FrostCEOBuy500,000$4.77$2,385,000.003,068,951  
12/28/2020Phillip FrostCEOBuy300,000$4.00$1,200,000.003,068,951  
11/9/2020Phillip FrostCEOBuy250,000$3.18$795,000.003,068,951  
10/30/2020Phillip FrostCEOBuy600,000$3.45$2,070,000.003,068,951  
8/26/2020Steven D. RubinVPBuy10,000$3.99$39,900.00  
6/2/2020Phillip FrostCEOBuy100,000$2.42$242,000.003,068,951  
5/28/2020Phillip FrostCEOBuy100,000$2.23$223,000.00
5/26/2020Phillip FrostCEOBuy250,000$2.20$550,000.003,068,951  
5/7/2020Phillip FrostCEOBuy400,000$1.95$780,000.003,068,951  
4/17/2020Phillip FrostCEOBuy325,000$1.66$539,500.003,068,951  
4/15/2020Phillip FrostCEOBuy200,000$1.55$310,000.003,068,951  
4/7/2020Phillip FrostCEOBuy400,000$1.28$512,000.003,068,951  
4/3/2020Phillip FrostCEOBuy50,000$1.23$61,500.003,068,951  
4/1/2020Phillip FrostCEOBuy643,549$1.17$752,952.333,068,951  
3/30/2020Phillip FrostCEOBuy161,968$1.35$218,656.803,068,951  
3/26/2020Phillip FrostCEOBuy200,000$1.38$276,000.003,068,951  
3/19/2020Phillip FrostCEOBuy100,000$1.44$144,000.00
3/12/2020Anthony J JapourDirectorBuy500$1.51$755.001,000  
3/10/2020Phillip FrostCEOBuy300,000$1.61$483,000.003,068,951  
3/3/2020Anthony J JapourDirectorBuy500$1.47$735.00500  
3/2/2020Phillip FrostCEOBuy100,000$1.49$149,000.003,068,951  
2/27/2020Phillip FrostCEOBuy250,000$1.44$360,000.003,068,951  
2/13/2020Phillip FrostCEOBuy100,000$1.57$157,000.003,068,951  
2/11/2020Phillip FrostCEOBuy14,239$1.59$22,640.013,068,951  
2/6/2020Phillip FrostCEOBuy50,000$1.58$79,000.003,068,951  
1/30/2020Phillip FrostCEOBuy100,000$1.42$142,000.003,068,951  
1/23/2020Phillip FrostCEOBuy50,000$1.63$81,500.003,068,951  
1/17/2020Phillip FrostCEOBuy22,262$1.56$34,728.723,068,951  
1/13/2020Phillip FrostCEOBuy50,000$1.44$72,000.003,068,951  
1/10/2020Phillip FrostCEOBuy50,000$1.48$74,000.003,068,951  
1/8/2020Phillip FrostCEOBuy50,000$1.47$73,500.003,068,951  
12/30/2019Phillip FrostCEOBuy100,000$1.47$147,000.003,068,951  
12/27/2019Phillip FrostCEOBuy100,000$1.49$149,000.00
12/19/2019Phillip FrostCEOBuy100,000$1.53$153,000.00
12/17/2019Phillip FrostCEOBuy75,000$1.50$112,500.003,068,951  
12/11/2019Phillip FrostCEOBuy100,000$1.50$150,000.003,068,951  
12/9/2019Phillip FrostCEOBuy50,000$1.59$79,500.003,068,951  
12/5/2019Phillip FrostCEOBuy50,000$1.62$81,000.00
12/2/2019Phillip FrostCEOBuy50,000$1.56$78,000.003,068,951  
11/26/2019Phillip FrostCEOBuy100,000$1.55$155,000.003,068,951  
11/18/2019Phillip FrostCEOBuy100,000$1.48$148,000.003,068,951  
11/12/2019Phillip FrostCEOBuy200,000$1.44$288,000.003,068,951  
11/8/2019Phillip FrostCEOBuy50,000$1.48$74,000.003,068,951  
11/6/2019Phillip FrostCEOBuy350,000$1.49$521,500.003,068,951  
10/31/2019Phillip FrostCEOBuy50,000$1.43$71,500.003,068,951  
10/29/2019Phillip FrostCEOBuy200,000$1.47$294,000.003,068,951  
10/25/2019Jane Ph D HsiaoVice ChairmanBuy400,000$1.50$600,000.0024,475,147  
10/25/2019Phillip FrostCEOBuy2,000,000$1.50$3,000,000.003,068,951  
10/25/2019Richard C Pfenniger JrDirectorBuy25,000$1.45$36,250.00275,000  
10/25/2019Steven D RubinVPBuy15,000$1.50$22,500.005,744,147  
7/16/2019Phillip FrostCEOBuy50,000$2.12$106,000.003,068,951  
7/12/2019Phillip FrostCEOBuy50,000$2.16$108,000.003,068,951  
7/8/2019Phillip FrostCEOBuy100,000$2.23$223,000.003,068,951  
7/2/2019Phillip FrostCEOBuy50,000$2.42$121,000.003,068,951  
6/25/2019Phillip FrostCEOBuy100,000$2.01$201,000.003,068,951  
6/20/2019Phillip FrostCEOBuy50,000$2.04$102,000.003,068,951  
6/18/2019Phillip FrostCEOBuy50,000$2.02$101,000.003,068,951  
6/13/2019Phillip FrostCEOBuy50,000$1.92$96,000.003,068,951  
6/11/2019Phillip FrostCEOBuy50,000$1.87$93,500.003,068,951  
6/7/2019Phillip FrostCEOBuy50,000$1.87$93,500.003,068,951  
6/5/2019Phillip FrostCEOBuy150,000$1.92$288,000.003,068,951  
5/30/2019Phillip FrostCEOBuy50,000$1.86$93,000.003,068,951  
5/28/2019Phillip FrostCEOBuy200,000$1.90$380,000.003,068,951  
5/28/2019Robert Scott FishelDirectorBuy50,000$1.92$96,000.00  
5/22/2019Phillip FrostCEOBuy125,000$2.00$250,000.003,068,951  
5/22/2019Richard C Pfenniger JrDirectorBuy30,000$2.05$61,500.00250,000  
5/16/2019Phillip FrostCEOBuy100,000$2.02$202,000.003,068,951  
5/13/2019Phillip FrostCEOBuy200,000$1.99$398,000.003,068,951  
5/13/2019Richard C Pfenniger JrDirectorBuy50,000$2.05$102,500.00171,310  
5/10/2019Phillip FrostCEOBuy70,000$2.08$145,600.003,068,951  
5/9/2019Adam LogalInsiderBuy3,250$2.04$6,630.00176,012  
5/9/2019John A PaganelliDirectorBuy10,000$2.09$20,900.00351,740  
5/8/2019Phillip FrostCEOBuy907,000$2.11$1,913,770.003,068,951  
4/22/2019Phillip FrostCEOBuy80,000$2.32$185,600.003,068,951  
4/17/2019Phillip FrostCEOBuy50,000$2.42$121,000.003,068,951  
4/15/2019Phillip FrostCEOBuy10,000$2.47$24,700.003,068,951  
4/11/2019Phillip FrostCEOBuy30,000$2.49$74,700.003,068,951  
4/9/2019Phillip FrostCEOBuy10,000$2.51$25,100.003,068,951  
4/4/2019Phillip FrostCEOBuy20,000$2.53$50,600.003,068,951  
4/1/2019Phillip FrostCEOBuy20,000$2.58$51,600.003,068,951  
3/27/2019Phillip FrostCEOBuy100,000$2.49$249,000.003,068,951  
3/18/2019Phillip FrostCEOBuy40,000$2.47$98,800.003,068,951  
3/14/2019Phillip FrostCEOBuy250,000$2.45$612,500.003,068,951  
3/6/2019Phillip FrostCEOBuy50,000$2.57$128,500.003,068,951  
3/6/2019Steven D RubinVPBuy8,000$2.56$20,480.005,716,712  
2/28/2019Phillip FrostCEOBuy200,000$2.48$496,000.003,068,951  
1/31/2019Jane Ph D HsiaoVice ChairmanBuy10,000$7.96$79,600.0024,455,147  
1/16/2019Phillip FrostCEOBuy10,000$3.74$37,400.003,068,951  
1/14/2019Phillip FrostCEOBuy15,000$3.74$56,100.003,068,951  
1/11/2019Phillip FrostCEOBuy10,000$3.83$38,300.003,068,951  
1/9/2019Phillip FrostCEOBuy10,000$3.65$36,500.003,068,951  
1/7/2019Phillip FrostCEOBuy55,000$3.56$195,800.003,068,951  
1/4/2019Phillip FrostCEOBuy30,000$3.43$102,900.003,068,951  
1/2/2019Phillip FrostCEOBuy40,000$3.24$129,600.003,068,951  
12/31/2018Phillip FrostCEOBuy135,000$2.97$400,950.00  
12/31/2018Phillip FrostCEOBuy135,000$2.97$400,950.003,068,951  
12/28/2018Phillip FrostCEOBuy100,000$3.13$313,000.003,068,951  
12/28/2018Phillip FrostCEOBuy100,000$3.13$313,000.003,068,951  
9/7/2018Phillip FrostCEOBuy10,000$5.57$55,700.00  
9/5/2018Phillip FrostCEOBuy10,000$5.79$57,900.003,068,951  
8/30/2018Phillip FrostCEOBuy5,000$5.90$29,500.003,068,951  
8/28/2018Phillip FrostCEOBuy5,000$5.80$29,000.003,068,951  
8/24/2018Phillip FrostCEOBuy15,000$5.70$85,500.003,068,951  
8/17/2018Phillip FrostCEOBuy10,000$5.54$55,400.003,068,951  
8/13/2018Phillip FrostCEOBuy15,000$5.33$79,950.003,068,951  
8/9/2018Phillip FrostCEOBuy10,000$5.45$54,500.003,068,951  
7/30/2018Jane Ph D HsiaoVice ChairmanBuy30,000$4.35$130,500.0024,455,147  
7/27/2018Jane Ph D HsiaoVice ChairmanBuy20,000$4.30$86,000.0024,455,147  
7/26/2018Phillip FrostCEOBuy90,000$5.06$455,400.003,068,951  
7/24/2018Phillip FrostCEOBuy55,000$5.60$308,000.003,068,951  
7/20/2018Phillip FrostCEOBuy10,000$5.89$58,900.003,068,951  
7/18/2018Phillip FrostCEOBuy10,000$6.05$60,500.003,068,951  
7/16/2018Phillip FrostCEOBuy15,000$5.68$85,200.003,068,951  
7/11/2018Robert Scott FishelDirectorBuy2,500$6.00$15,000.00  
7/3/2018Phillip FrostCEOBuy10,000$4.75$47,500.003,068,951  
6/29/2018Phillip FrostCEOBuy7,720$4.71$36,361.203,068,951  
6/27/2018Phillip FrostCEOBuy10,000$4.75$47,500.003,068,951  
6/21/2018Phillip FrostCEOBuy30,000$4.54$136,200.003,068,951  
6/18/2018Phillip FrostCEOBuy14,299$4.34$62,057.663,068,951  
6/15/2018Phillip FrostCEOBuy10,000$4.42$44,200.003,068,951  
6/11/2018Phillip FrostCEOBuy10,000$4.22$42,200.003,068,951  
6/6/2018Phillip FrostCEOBuy30,000$4.05$121,500.003,068,951  
5/31/2018Phillip FrostCEOBuy3,900$3.76$14,664.003,068,951  
5/29/2018Robert Scott FishelDirectorBuy2,500$3.73$9,325.00  
5/25/2018Phillip FrostCEOBuy10,000$3.70$37,000.003,068,951  
5/23/2018Phillip FrostCEOBuy40,000$3.73$149,200.003,068,951  
5/21/2018Phillip FrostCEOBuy90,000$3.82$343,800.003,068,951  
5/18/2018Phillip FrostCEOBuy100,000$4.04$404,000.003,068,951  
5/14/2018Robert Scott FishelDirectorBuy1,800$4.79$8,622.00  
5/4/2018Phillip FrostCEOBuy26,000$3.14$81,640.003,068,951  
5/4/2018Robert Scott FishelDirectorBuy5,000$3.14$15,700.00  
5/2/2018Phillip FrostCEOBuy50,330$3.15$158,539.503,068,951  
4/30/2018Phillip FrostCEOBuy75,000$3.08$231,000.003,068,951  
4/25/2018Phillip FrostCEOBuy55,372$2.99$165,562.283,068,951  
4/25/2018Robert Scott FishelDirectorBuy12,500$2.97$37,125.00  
4/23/2018Phillip FrostCEOBuy75,000$3.04$228,000.003,068,951  
4/19/2018Phillip FrostCEOBuy10,000$3.17$31,700.003,068,951  
4/16/2018Phillip FrostCEOBuy50,000$3.02$151,000.003,068,951  
4/16/2018Robert Scott FishelDirectorBuy15,000$3.01$45,150.00  
4/13/2018Phillip FrostCEOBuy30,000$2.99$89,700.003,068,951  
4/13/2018Robert Scott FishelDirectorBuy10,000$3.02$30,200.00  
4/11/2018Phillip FrostCEOBuy43,000$3.06$131,580.003,068,951  
4/9/2018Phillip FrostCEOBuy80,000$3.04$243,200.003,068,951  
4/5/2018Phillip FrostCEOBuy10,000$3.25$32,500.003,068,951  
4/3/2018Phillip FrostCEOBuy153,000$3.00$459,000.003,068,951  
3/28/2018Phillip FrostCEOBuy80,000$3.07$245,600.003,068,951  
3/26/2018Phillip FrostCEOBuy26,000$3.19$82,940.003,068,951  
3/23/2018Phillip FrostCEOBuy25,000$3.27$81,750.003,068,951  
3/21/2018Phillip FrostCEOBuy30,000$3.38$101,400.003,068,951  
3/19/2018Phillip FrostCEOBuy40,000$3.51$140,400.003,068,951  
3/15/2018Phillip FrostCEOBuy61,000$3.32$202,520.003,068,951  
3/13/2018Adam LogalInsiderBuy2,065$3.40$7,021.00  
3/12/2018Phillip FrostCEOBuy25,000$3.48$87,000.003,068,951  
3/7/2018Phillip FrostCEOBuy75,000$3.29$246,750.003,068,951  
3/7/2018Steven D RubinVPBuy6,000$3.25$19,500.005,691,915  
3/2/2018Phillip FrostCEOBuy364,800$2.94$1,072,512.003,068,951  
See Full Table

SEC Filings (Institutional Ownership Changes) for OPKO Health (NASDAQ:OPK)

28.51% of OPKO Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OPKO Health Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/1/2021UBS Asset Management Americas Inc.526,323$2.08M0.0%+21.3%0.079%
2/25/2021Dimensional Fund Advisors LP5,612,566$22.17M0.0%+10.4%0.838%
2/24/2021Bank Julius Baer & Co. Ltd Zurich12,911$51K0.0%N/A0.002%
2/23/2021Principal Financial Group Inc.1,044,046$4.12M0.0%+5.6%0.156%
2/18/2021Truist Financial Corp34,875$0.14M0.0%N/A0.005%
2/17/2021United Capital Financial Advisers LLC12,335$49K0.0%-54.0%0.002%
2/17/2021Cetera Investment Advisers15,960$63K0.0%N/A0.002%
2/17/2021Cetera Advisor Networks LLC103,312$0.41M0.0%N/A0.015%
2/16/2021Zacks Investment Management13,150$52K0.0%N/A0.002%
2/16/2021Squarepoint Ops LLC246,102$0.97M0.0%-74.5%0.037%
2/16/2021Morgan Stanley1,412,909$5.58M0.0%-22.3%0.211%
2/16/2021Tudor Investment Corp Et Al163,325$0.65M0.0%+102.6%0.024%
2/16/2021Nuveen Asset Management LLC3,239,120$12.80M0.0%-9.7%0.483%
2/16/2021Captrust Financial Advisors50,500$0.20M0.0%+63.4%0.008%
2/16/2021Price T Rowe Associates Inc. MD245,170$0.97M0.0%+43.3%0.037%
2/16/2021Virginia Retirement Systems ET AL76,200$0.30M0.0%+59.7%0.011%
2/16/2021ETF Managers Group LLC325,883$1.32M0.0%-13.2%0.049%
2/16/2021Engineers Gate Manager LP84,160$0.33M0.0%-62.4%0.013%
2/16/2021Parametrica Management Ltd31,850$0.13M0.1%N/A0.005%
2/16/2021Charles Schwab Investment Management Inc.3,528,264$13.94M0.0%+7.2%0.527%
2/13/2021Essex Investment Management Co. LLC95,839$0.38M0.0%-23.3%0.014%
2/13/2021American International Group Inc.231,209$0.91M0.0%-2.8%0.035%
2/12/2021Matrix Asset Advisors Inc. NY10,000$40K0.0%N/A0.001%
2/12/2021Beacon Pointe Advisors LLC10,000$40K0.0%N/A0.001%
2/12/2021Sequoia Financial Advisors LLC16,111$64K0.0%N/A0.002%
2/12/2021Kings Point Capital Management12,225$48K0.0%-33.8%0.002%
2/12/2021Penserra Capital Management LLC15,525$61K0.0%+171.2%0.002%
2/12/2021Federated Hermes Inc.14,574$58K0.0%-17.2%0.002%
2/12/2021LPL Financial LLC47,809$0.19M0.0%+117.2%0.007%
2/12/2021The Manufacturers Life Insurance Company 243,039$0.96M0.0%+3.5%0.036%
2/12/2021Credit Suisse AG841,981$3.33M0.0%-26.3%0.126%
2/12/2021Nordea Investment Management AB1,269,568$5.02M0.0%N/A0.189%
2/12/2021Mercer Global Advisors Inc. ADV16,100$64K0.0%-16.1%0.002%
2/11/2021Wetherby Asset Management Inc.15,146$60K0.0%-41.7%0.002%
2/11/2021Northern Trust Corp7,509,164$29.66M0.0%-3.2%1.121%
2/11/2021Linscomb & Williams Inc.11,000$43K0.0%N/A0.002%
2/11/2021Barclays PLC162,781$0.64M0.0%-11.7%0.024%
2/11/2021Teacher Retirement System of Texas40,042$0.16M0.0%+60.1%0.006%
2/11/2021Oppenheimer & Co. Inc.12,500$49K0.0%-65.3%0.002%
2/10/2021Rhumbline Advisers713,901$2.82M0.0%+13.2%0.107%
2/10/2021Renaissance Technologies LLC594,343$2.35M0.0%N/A0.089%
2/10/2021Brighton Jones LLC34,000$0.13M0.0%+13.3%0.005%
2/10/2021Boston Private Wealth LLC21,770$86K0.0%N/A0.003%
2/10/2021HighTower Advisors LLC54,139$0.22M0.0%-4.0%0.008%
2/9/2021Wells Fargo & Company MN1,559,598$6.16M0.0%+55.7%0.233%
2/9/2021Bank of New York Mellon Corp1,890,716$7.47M0.0%-4.8%0.282%
2/9/2021Sigma Planning Corp15,402$61K0.0%+14.9%0.002%
2/9/2021Landscape Capital Management L.L.C.270,178$1.07M0.2%N/A0.040%
2/9/2021ProShare Advisors LLC191,509$0.76M0.0%+22.2%0.029%
2/8/2021Alliancebernstein L.P.602,500$2.38M0.0%+0.8%0.090%
2/8/2021New York State Common Retirement Fund342,100$1.35M0.0%+1.6%0.051%
2/8/2021Coe Capital Management LLC36,500$0.14M0.2%N/A0.005%
2/5/2021IndexIQ Advisors LLC156,303$0.62M0.0%+11.5%0.023%
2/5/2021BlackRock Inc.37,628,639$148.63M0.0%+3.5%5.616%
2/5/2021Aperio Group LLC100,821$0.40M0.0%-4.1%0.015%
2/5/2021SG Americas Securities LLC159,740$0.63M0.0%-33.8%0.024%
2/4/2021Regentatlantic Capital LLC15,000$59K0.0%N/A0.002%
2/4/2021Daiwa Securities Group Inc.274,260$1.08M0.0%-1.6%0.041%
2/4/2021National Asset Management Inc.25,500$0.10M0.0%+64.5%0.004%
2/4/2021Clear Harbor Asset Management LLC10,100$40K0.0%+10,000.0%0.002%
2/4/2021Cambridge Investment Research Advisors Inc.307,921$1.22M0.0%-16.4%0.046%
2/4/2021GSA Capital Partners LLP26,987$0.11M0.0%-87.3%0.004%
2/4/2021State of Wisconsin Investment Board572,000$2.26M0.0%-11.1%0.085%
2/3/2021State of New Jersey Common Pension Fund D465,959$1.84M0.0%N/A0.070%
2/2/2021California Public Employees Retirement System894,954$3.54M0.0%-1.9%0.134%
2/2/2021First Trust Advisors LP1,172,985$4.63M0.0%N/A0.175%
2/1/2021Ausdal Financial Partners Inc.24,000$83K0.0%+26.3%0.004%
2/1/2021AE Wealth Management LLC76,802$0.30M0.0%-26.4%0.011%
2/1/2021Victory Capital Management Inc.170,697$0.67M0.0%+49.0%0.025%
1/29/2021Creative Planning42,782$0.17M0.0%+7.2%0.006%
1/28/2021Arizona State Retirement System126,264$0.50M0.0%-3.9%0.019%
1/28/2021Dupont Capital Management Corp77,788$0.31M0.0%-6.9%0.012%
1/27/2021Norris Perne & French LLP MI59,500$0.24M0.0%+13.3%0.009%
1/25/2021Nisa Investment Advisors LLC22,200$88K0.0%+29.4%0.003%
1/25/2021Janney Montgomery Scott LLC23,600$93K0.0%-11.1%0.004%
1/25/2021Strs Ohio228,200$0.90M0.0%-9.6%0.034%
1/22/2021Aries Wealth Management15,000$66K0.0%N/A0.002%
1/21/2021Grandview Asset Management LLC19,450$77K0.1%N/A0.003%
1/20/2021Pacer Advisors Inc.29,738$0.12M0.0%-29.8%0.004%
1/20/2021Cumberland Advisors Inc.19,500$77K0.0%N/A0.003%
1/20/2021Kestra Advisory Services LLC39,411$0.16M0.0%+129.8%0.006%
1/20/2021Lehman & Derafelo Financial Resources LLC52,100$0.21M0.1%+56.5%0.008%
1/14/2021Kovack Advisors Inc.13,051$52K0.0%-18.7%0.002%
1/13/2021Sowell Financial Services LLC35,910$0.14M0.0%-12.0%0.005%
12/16/2020Wetherby Asset Management Inc.25,974$96K0.0%N/A0.004%
12/14/2020Strs Ohio252,300$0.93M0.0%-8.5%0.038%
12/11/2020Virtu Financial LLC48,271$0.18M0.0%-39.2%0.007%
12/10/2020Mercer Global Advisors Inc. ADV19,200$71K0.0%N/A0.003%
11/30/2020Platform Technology Partners29,000$0.11M0.1%+37.4%0.004%
11/20/2020Kathmere Capital Management LLC21,988$86K0.0%N/A0.003%
11/17/2020Levin Capital Strategies L.P.15,000$55K0.0%-85.0%0.002%
11/17/2020Captrust Financial Advisors30,900$0.12M0.0%+6,080.0%0.005%
11/16/2020Cubist Systematic Strategies LLC397,710$1.47M0.0%+2,038.6%0.059%
11/16/2020AQR Capital Management LLC592,533$2.19M0.0%N/A0.088%
11/16/2020Squarepoint Ops LLC965,645$3.56M0.0%+197.8%0.144%
11/16/2020ExodusPoint Capital Management LP184,669$0.68M0.0%+201.9%0.028%
11/16/2020Engineers Gate Manager LP223,828$0.83M0.0%+188.4%0.033%
11/13/2020Transcend Wealth Collective LLC42,000$0.16M0.0%N/A0.006%
11/13/2020Morgan Stanley1,818,438$6.71M0.0%+152.5%0.271%
11/13/2020Wetherby Asset Management Inc.25,974$96K0.0%N/A0.004%
Data available starting January 2016

See Full Table
OPKO Health logo
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $4.70
$4.55
$4.75

50 Day Range

MA: $5.00
$4.36
$5.99

52 Week Range

Now: $4.70
$1.12
$6.47

Volume

6,303,864 shs

Average Volume

8,628,944 shs

Market Capitalization

$3.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Who are the company insiders with the largest holdings of OPKO Health?

OPKO Health's top insider investors include:
  1. Jane Ph D Hsiao (Vice Chairman)
  2. Steven D Rubin (VP)
  3. Phillip Md Et Al Frost (CEO)
  4. John A Paganelli (Director)
  5. Richard C Pfenniger Jr (Director)
  6. Adam Logal (Insider)
  7. Anthony J Japour (Director)
  8. Robert Scott Fishel (Director)
  9. Steven D Rubin (VP)

Who are the major institutional investors of OPKO Health?

OPKO Health's top institutional investors include:
  1. BlackRock Inc. — 5.62%
  2. Northern Trust Corp — 1.12%
  3. Dimensional Fund Advisors LP — 0.84%
  4. Charles Schwab Investment Management Inc. — 0.53%
  5. Nuveen Asset Management LLC — 0.48%
  6. Bank of New York Mellon Corp — 0.28%

Which institutional investors are selling OPKO Health stock?

Within the previous quarter, OPK stock was sold by these institutional investors:
  1. Squarepoint Ops LLC
  2. Morgan Stanley
  3. Nuveen Asset Management LLC
  4. Credit Suisse AG
  5. Northern Trust Corp
  6. GSA Capital Partners LLP
  7. Engineers Gate Manager LP
  8. Bank of New York Mellon Corp

Which institutional investors are buying OPKO Health stock?

Within the previous quarter, OPK stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Nordea Investment Management AB
  3. First Trust Advisors LP
  4. Renaissance Technologies LLC
  5. Wells Fargo & Company MN
  6. Dimensional Fund Advisors LP
  7. State of New Jersey Common Pension Fund D
  8. Landscape Capital Management L.L.C.
During the last year, these company insiders have bought OPKO Health stock:
  1. Jane Ph D Hsiao (Vice Chairman)
  2. Steven D Rubin (VP)
  3. Phillip Md Et Al Frost (CEO)
  4. John A Paganelli (Director)
  5. Richard C Pfenniger Jr (Director)
  6. Adam Logal (Insider)
  7. Anthony J Japour (Director)
  8. Robert Scott Fishel (Director)
  9. Steven D Rubin (VP)
Miss this “Ultima Event” at your own financial risk
From Traders News Media   |   Ad
Some of the smartest people I know have been texting me, relieved to have successfully claimed their seat - so I wanted you to know about it before it’s too late.
Here’s the link to reserve your free seat